Gene · 722
Papers2,921
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 2,921
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Solar-induced efficient propylparaben photodegradation by nitrogen vacancy engineered reticulate g-C3N4: Morphology, activity and mechanism. | Sci Total Environ | 2023 | 36208767 | PubTator, text mining | PubMed |
| Intracellular complement: Evidence, definitions, controversies, and solutions. | Immunol Rev | 2023 | 36100972 | PubTator, text mining | PubMed |
| Genetic variability shapes the alternative pathway complement activity and predisposition to complement-related diseases. | Immunol Rev | 2023 | 36089777 | PubTator, text mining | PubMed |
| Vascular surgery patients with elevated neutrophil-to-lymphocyte ratios have downregulated neutrophil complement RNA expression. | Blood Adv | 2023 | 36006440 | PubTator, text mining | PubMed |
| Evaluation of C4b as an adjunct marker in symptomatic RT-PCR negative Covid-19 cases. | Indian J Clin Biochem | 2023 | 35756690 | PubTator, text mining | PubMed |
| The lymph node transcriptome of unicentric and idiopathic multicentric Castleman disease. | Haematologica | 2023 | 35484648 | PubTator, text mining | PubMed |
| Seed amplification and RT-QuIC assays to investigate protein seed structures and strains. | Cell Tissue Res | 2023 | 35258712 | PubTator, text mining | PubMed |
| Increased Gal-3BP plasma levels in hospitalized patients infected with SARS-CoV-2. | Clin Exp Med | 2023 | 35076790 | PubTator, text mining | PubMed |
| Immunostimulants for shrimp aquaculture: paving pathway towards shrimp sustainability. | Environ Sci Pollut Res Int | 2023 | 35025041 | PubTator, text mining | PubMed |
| Safety and efficacy of eye drops from umbilical cord blood platelet lysate to treat resistant corneal ulcer. | Med Hypothesis Discov Innov Ophthalmol | 2022 | 37641608 | PubTator, text mining | PubMed |
| Complement C1q-dependent excitatory and inhibitory synapse elimination by astrocytes and microglia in Alzheimer's disease mouse models. | Nat Aging | 2022 | 37118504 | PubTator, text mining | PubMed |
| Combined Therapy with Laser and Autologous Topical Serum for Facial Rejuvenation: A Multiple Case Series Report. | J Cutan Aesthet Surg | 2022 | 37035594 | PubTator, text mining | PubMed |
| Therapeutic Efficacy of a Plasma Rich in Growth Factors Gel Combined with Fractional Ablative Laser in the Management of Post-acne Scars. | J Cutan Aesthet Surg | 2022 | 37035588 | PubTator, text mining | PubMed |
| Clinical use of Plasma Protein from Platelet in Degenerative Joint Disease: A Prospective Study. | J Orthop Case Rep | 2022 | 37013232 | PubTator, text mining | PubMed |
| How COVID-19 and other pathological conditions and medical treatments activate our intravascular innate immune system. | Front Immunol | 2022 | 36820001 | PubTator, text mining | PubMed |
| Quantitative plasma proteomics identifies metallothioneins as a marker of acute-on-chronic liver failure associated acute kidney injury. | Front Immunol | 2022 | 36776389 | PubTator, text mining | PubMed |
| Group A Streptococcus Infections: Their Mechanisms, Epidemiology, and Current Scope of Vaccines. | Cureus | 2022 | 36721580 | PubTator, text mining | PubMed |
| Identification of two molecular subtypes and a novel prognostic model of lung adenocarcinoma based on a cuproptosis-associated gene signature. | Front Genet | 2022 | 36712848 | PubTator, text mining | PubMed |
| Improved Hemocompatibility on Superhemophobic Micro-Nano-Structured Titanium Surfaces. | Bioengineering (Basel) | 2022 | 36671615 | PubTator, text mining | PubMed |
| Advances and Innovations of 3D Bioprinting Skin. | Biomolecules | 2022 | 36671440 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/722/papers?page=21